|Jmol-3D images||Image 1|
|Molar mass||215.6778 g/mol|
|Melting point||220–221 °C (hydrochloride)|
| (what is: / ?)
Except where noted otherwise, data are given for materials in their standard state (at 25 °C (77 °F), 100 kPa)
2C-C is a psychedelic drug of the 2C family. It was first synthesized by Alexander Shulgin, sometimes used as an entheogen. The full name of the chemical is 2,5-dimethoxy-4-chlorophenethylamine. In his book PiHKAL (Phenethylamines i Have Known And Loved), Shulgin lists the dosage range as 20–40 mg. 2C-C is usually taken orally, but may also be insufflated. 2C-C is schedule I of section 202(c) of the Controlled Substances Act in the United States, signed into law as of July, 2012 under the Food and Drug Administration Safety and Innovation Act.
- The visual effects of 2C-C are similar to those of LSD or psilocybin mushrooms, though much less intense at commonly taken doses. Unique among the psychedelics, 2C-C is intensely relaxing, almost sedating. Nasal insufflation (extremely painful) or rectal administration bypasses first pass metabolism, requiring about half the dose normally used orally; the effects occur within 2–30 minutes via these routes and tend to last about an hour or two. There are very few known negative side effects attributed to 2C-C and nearly no hangover period except headaches after repeated doses.
- The effects can take up to two hours to manifest.
- Over the approximate dose range 20–40 mg, effects last respectively, approximately, 4 to 8 hours. Increased dosages increase the duration of the trip.
- No deaths have been attributed to 2C-C.
Drug prohibition laws
Sveriges riksdags health ministry Statens folkhälsoinstitut classified 2C-C as "health hazard" under the act Lagen om förbud mot vissa hälsofarliga varor (translated Act on the Prohibition of Certain Goods Dangerous to Health) as of Mar 1, 2005, in their regulation SFS 2005:26 listed as 2,5-dimetoxi-4-klorfenetylamin (2C-C), making it illegal to sell or possess.
- Shulgin, Alexander; Ann Shulgin (September 1991). PiHKAL: A Chemical Love Story. Berkeley, California: Transform Press. ISBN 0-9630096-0-5. OCLC 25627628.
- "S. 3187: Food and Drug Administration Safety and Innovation Act, Subtitle D-Synthetic Drugs". FDA. June 27, 2012. Retrieved July 12, 2012.